Filing Details

Accession Number:
0001144204-12-056461
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-16 18:03:48
Reporting Period:
2012-10-16
Filing Date:
2012-10-16
Accepted Time:
2012-10-16 18:03:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253170 Srinivas Akkaraju C/O Intercept Pharmaceuticals, Inc.
18 Desbrosses St.
New York NY 10013
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2012-10-16 700,000 $15.00 700,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Reflects securities purchased in the Issuer's initial public offering.
  2. Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Management II, L.L.C. ("NLVM II"). Dr. Srinivas Akkaraju, in his capacity as member of NLVM II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Akkaraju disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.